NovaBay Pharmaceuticals Inc (NYSE American:NBY)

3.40
Delayed Data
As of Feb 22
 -0.05 / -1.45%
Today’s Change
2.25
Today|||52-Week Range
5.00
-11.69%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close3.45
Today’s open3.40
Day’s range3.40 - 3.40
Volume233
Average volume (3 months)11,901
Market cap$53.1M
Data as of 12:55pm ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)+79.47%
Earnings growth (this year)+59.05%
Earnings growth (next 5 years)--
Revenue growth (last year)+171.56%
P/E ratioNM
Price/Sales2.61
Price/Book7.42

Competitors

 Today’s
change
Today’s
% change
--Innovative Pharmaceu...-0.01-17.02%
AGLEAeglea Bio Therapeut...+0.01+0.16%
RNNRexahn Pharmaceutica...-0.01-0.57%
PTNPalatin Technologies...-0.01-0.51%
Data as of 8:00pm ET, 02/22/2018

Financials

Next reporting dateMarch 21, 2018
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$11.9M
Annual profit (last year)-$13.2M
Net profit margin-110.54%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer
Jack J. McGovern
Corporate headquarters
Emeryville, California

Forecasts